纳米粒子驱动的活性氧物种疗法:骨髓瘤治疗的新前沿
Lei He1, Pamela Habibovic1, Sabine van Rijt1
1Department of Instructive Biomaterials Engineering, MERLN Institute for Technology Inspired Regenerative Medicine, Maastricht University, P.O. Box 616, 6200 MD Maastricht, the Netherlands.
概括
反应性氧物种 (ROS) 是骨髓瘤 (OS) 治疗的关键. 纳米粒子增强ROS的产生,以克服癌症.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 纳米技术纳米技术
背景情况:
- 反应性氧物种 (ROS) 对于骨髓瘤 (OS) 治疗至关重要,诱导细胞死亡.
- OS细胞具有更高的ROS水平,创造了一个治疗窗口,但它们的抗氧化防御限制了传统治疗.
- 基于纳米粒子的策略正在出现,以增强ROS生成,以改善OS疗法.
研究的目的:
- 系统地审查和分类用于OS处理的ROS升级调节纳米粒子.
- 讨论这些纳米平台的治疗潜力和作用机制.
- 确定OS疗法开发纳米材料的挑战和未来方向.
主要方法:
- 文学审查和ROS生成纳米粒子的系统分类.
- 对纳米粒子机制,治疗疗效和挑战的分析.
- 讨论未来的研究和开发在纳米医学的OS.
主要成果:
- 产生ROS的纳米颗粒为克服OS细胞抗氧化防御提供了一个有希望的策略.
- 基于机制的分类揭示了ROS调制的各种方法.
- 虽然取得了重大进展,但仍需要为纳米平台设计制定一个全面的框架.
结论:
- 基于纳米粒子的ROS上调是一种选择性骨髓瘤治疗的可行策略.
- 需要进一步的研究来优化纳米平台的设计和克服临床限制.
- 本次审查提供了一个框架,以指导开发下一代纳米材料用于骨髓瘤治疗.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K


